Thermo Fisher Scientific Acquires CorEvitas from Audax Private Equity
July 6, 2023
Thermo Fisher Scientific agreed to acquire CorEvitas, a Waltham, Massachusetts–based real-world evidence (RWE) and clinical registries provider, from Audax Private Equity for $912.5 million in cash. The acquisition, completed August 14, 2023, will fold CorEvitas (approximately 300 employees; expected 2023 revenue ~$110M) into Thermo Fisher’s Laboratory Products and Biopharma Services segment to expand its RWE and life‑sciences data capabilities.
- Buyers
- Thermo Fisher Scientific Inc.
- Targets
- CorEvitas, LLC
- Sellers
- Audax Private Equity
- Industry
- Data & Analytics
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CorEvitas Acquires Vestrum Health
July 22, 2021
Data & Analytics
CorEvitas, a provider of curated real-world evidence and a portfolio company of Audax Private Equity, has added Vestrum Health to its organization. The acquisition brings Vestrum’s retina-focused EHR data analytics and real-world evidence capabilities into CorEvitas’ registry and analytics platform to expand specialty EHR data and RWE services for retina practices and biopharmaceutical customers.
-
CorEvitas Acquires Pregistry to Expand Pregnancy Safety Registries
November 21, 2022
Healthcare Services
CorEvitas LLC, a Waltham, Massachusetts-based real-world data intelligence company and Audax Private Equity portfolio company, has acquired Pregistry, LLC, a Los Angeles-based specialist in pregnancy exposure registries and observational safety studies. The deal expands CorEvitas' syndicated registry capabilities and pharmacovigilance services to include pregnancy-focused real-world evidence for pharmaceutical and biotech customers; terms were not disclosed.
-
Target RWE Acquires NoviSci Inc.
January 15, 2021
Healthcare Services
Target RWE, a Durham-based real-world evidence solutions company, has acquired NoviSci, Inc., a software analytics and services firm that applies epidemiologic methods and causal inference to health data. Amgen Inc. also made a strategic investment in the combined company, joining existing investors Norwest Venture Partners and 22C Capital to support growth; financial terms were not disclosed.
-
Athagoras Acquires Quantify Research
January 8, 2025
Healthcare Services
Athagoras, a Munich-based life sciences consulting platform, has acquired Quantify Research, a Nordic-headquartered specialist in real-world evidence (RWE), health economics (HEOR) and market access. The acquisition expands Athagoras' RWE and market access capabilities and strengthens its presence in the Nordic region and Asia-Pacific to better serve global pharmaceutical clients.
-
Datavant Acquires Aetion
July 13, 2025
Healthcare Services
Datavant has completed its acquisition of Aetion, bringing the real-world evidence (RWE) platform into Datavant’s Life Sciences business to create an end-to-end data feasibility and analysis offering. The deal combines Datavant’s data connectivity network with Aetion’s RWE analytics to expand capabilities for biopharma, device makers, payers, and regulators.
-
Audax Private Equity Acquires Thermogenics, Inc.
June 2, 2022
Manufacturing
Audax Private Equity has acquired Thermogenics, Inc., a North American designer, manufacturer and service provider of coil‑tube boilers, from Ironbridge Equity Partners and certain other minority investors. The transaction — the first investment by Audax's Origins Fund I — will support Thermogenics' growth initiatives and expansion of its boiler product and service offerings across Canada and the U.S.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.